NCT02668406View on ClinicalTrials.gov

Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis

CompletedOBSERVATIONAL
Enrollment

4,203

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
MelioidosisSystemic Inflammatory Response SyndromeSuspected or Confirmed Bloodstream Infections
Interventions
OTHER

Venous blood sampling (2 timepoints) (Phase A and B)

8.5ml at Day 1 + 8.5ml at Day 5

OTHER

Venous blood sampling (1 timepoint) (Phase A and B)

8.5ml at Day 1

OTHER

Voided urine sampling (first sample) (Phase A)

At least 20ml upon confirmation of being part of one of the 3 study groups

OTHER

Voided urine sampling (second sample) (Phase A)

At least 20ml during routine hospital stay or routine follow-up visit

Trial Locations (2)

Unknown

HOPE Community Medical Center, Phnom Penh

Sihanouk Hospital Center of HOPE (SHCH), Cambodia, Phnom Penh

Sponsors

Collaborators (1)

SRI International
All Listed Sponsors
collaborator

Sihanouk Hospital Center of HOPE

OTHER

collaborator

SRI International

INDUSTRY

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT02668406 - Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis | Biotech Hunter | Biotech Hunter